Literature DB >> 14580735

Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction?

Gregory P Walcott1, Cheryl R Killingsworth, Raymond E Ideker.   

Abstract

Sufficiently strong defibrillation shocks will cause temporary or permanent damage to the heart. Weak defibrillation shocks do not cause any damage to the heart but also do not defibrillate. A relevant and practical question is what range of shock energies is most likely to defibrillate while not causing damage to the heart. This question is most difficult to answer in the pre-hospital defibrillation setting where the patients' size and shape vary, placement of the defibrillation patches vary, and the etiology of their arrhythmia varies. Unlike internal defibrillators, which are tested at implantation, efficacy of an external defibrillator is determined only once, when it is most needed. This review discusses shock damage and dysfunction caused by monophasic waveforms as well as biphasic waveforms. Evidence is presented suggesting that for perfused hearts, the threshold for damage is well above any shock size delivered clinically. For non-perfused hearts, both in humans and animals, evidence is presented that monophasic shocks of up to 5 J/kg do not cause any more cardiac damage/dysfunction than that associated with smaller shocks and that much of this damage is caused by the ischemic period itself rather than the shock. Although many patients can be defibrillated with 150 J (2.2 J/kg) biphasic shocks, some patients may require biphasic shocks up to 360 J (5 J/kg) to be defibrillated. Studies still need to be performed comparing the efficacy and damaging effects of 360 J biphasic shocks to 150 J biphasic shocks. Until those studies are completed, it seems reasonable to use the same 360 J (5 J/kg) energy limit for biphasic shocks as for monophasic shocks.

Entities:  

Mesh:

Year:  2003        PMID: 14580735     DOI: 10.1016/s0300-9572(03)00161-8

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  21 in total

1.  Control of action potential duration alternans in canine cardiac ventricular tissue.

Authors:  Uche B Kanu; Shahriar Iravanian; Robert F Gilmour; David J Christini
Journal:  IEEE Trans Biomed Eng       Date:  2010-10-28       Impact factor: 4.538

2.  The subcutaneous defibrillator will replace the transvenous defibrillator.

Authors:  Ian Crozier
Journal:  J Interv Card Electrophysiol       Date:  2011-04-27       Impact factor: 1.900

3.  TNF-α blockade improves early post-resuscitation survival and hemodynamics in a swine model of ischemic ventricular fibrillation.

Authors:  James T Niemann; Scott T Youngquist; Atman P Shah; Joseph L Thomas; John P Rosborough
Journal:  Resuscitation       Date:  2012-06-07       Impact factor: 5.262

4.  Placement of implantable cardioverter-defibrillators in paediatric and congenital heart defect patients: a pipeline for model generation and simulation prediction of optimal configurations.

Authors:  Lukas J Rantner; Fijoy Vadakkumpadan; Philip J Spevak; Jane E Crosson; Natalia A Trayanova
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

5.  Phase Entrainment of Induced Ventricular Fibrillation: A Human Feasibility and Proof of Concept Study.

Authors:  Arun V Holden; Gordon A Begg; Katrina Bounford; Berthold Stegemann; Muzahir H Tayebjee
Journal:  J Atr Fibrillation       Date:  2019-12-31

6.  Personalized Low-Energy Defibrillation Through Feedback Based Resynchronization Therapy.

Authors:  Ilija Uzelac; Flavio H Fenton
Journal:  Comput Cardiol (2010)       Date:  2021-02-10

7.  Evaluation of acute cardiac and chest wall damage after shocks with a subcutaneous implantable cardioverter defibrillator in Swine.

Authors:  Cheryl R Killingsworth; Sharon B Melnick; Silvio H Litovsky; Raymond E Ideker; Gregory P Walcott
Journal:  Pacing Clin Electrophysiol       Date:  2013-05-28       Impact factor: 1.976

8.  Termination of atrial fibrillation using pulsed low-energy far-field stimulation.

Authors:  Flavio H Fenton; Stefan Luther; Elizabeth M Cherry; Niels F Otani; Valentin Krinsky; Alain Pumir; Eberhard Bodenschatz; Robert F Gilmour
Journal:  Circulation       Date:  2009-07-27       Impact factor: 29.690

9.  Energy conserving chemical defibrillation of ventricular fibrillation: A randomized two phase controlled blinded trial.

Authors:  Keith A Marill; David D Salcido; Matthew L Sundermann; Allison C Koller; James J Menegazzi
Journal:  Resuscitation       Date:  2016-03-31       Impact factor: 5.262

10.  Hypocalcemia following resuscitation from cardiac arrest revisited.

Authors:  Scott T Youngquist; Theodore Heyming; John P Rosborough; James T Niemann
Journal:  Resuscitation       Date:  2009-11-13       Impact factor: 5.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.